Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Argyropoulos, Christos ^a   Wang, Kai ^b   McClarty, Sara ^b   Huang, David ^b,c   Bernardo, Jose ^a   Ellis, Demetrius ^e   Orchard, Trevor ^d   Galas, David ^c,e,f   Johnson, John ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f Pacific Nothwest Diabetes Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE TARGETING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MALE; MICROALBUMINURIA; MOLECULAR DYNAMICS; POLYMERASE CHAIN REACTION; PREDICTION; QUANTITATIVE ANALYSIS; RNA FINGERPRINTING; RNA TRANSLATION; SIGNAL TRANSDUCTION; SYNDROME DELINEATION;

BAYES THEOREM; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS;

EID: 84872860732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054662     Document Type: Article

References (64)

1. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, et al. (2004) Nephropathy in diabetes. Diabetes Care 27Suppl 1: S79-83.
2. Kanwar YS, Sun L, Xie P, Liu F-Y, Chen S, (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6: 395-423 doi:10.1146/annurev.pathol.4.110807.092150.
3. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655 doi:10.1016/j.cell.2009.01.035.
4. Lee RC, Ambros V, (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864 doi:10.1126/science.1065329.
5. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840 doi:10.1038/nature09267.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Kantharidis P, Wang B, Carew RM, Lan HY, (2011) Diabetes complications: the microRNA perspective. Diabetes 60: 1832-1837 doi:10.2337/db11-0082.
8. Bhatt K, Mi Q-S, Dong Z, (2011) microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol 300: F602-610 doi:10.1152/ajprenal.00727.2010.
9. Kato M, Arce L, Natarajan R, (2009) MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 4: 1255-1266 doi:10.2215/CJN.00520109.
10. Lorenzen JM, Haller H, Thum T, (2011) MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7: 286-294 doi:10.1038/nrneph.2011.26.
11. Roweis, Sam T, (1998) EM Algororithms for PCA and SPCA. Advances in Neural Information Processing Systems. Colorado, USA, 1997: The MIT Press, Vol. 10: 626-632.
12. Stacklies W, Redestig H, Scholz M, Walther D, Selbig J, (2007) pcaMethods-a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23: 1164-1167 doi:10.1093/bioinformatics/btm069.
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80 doi:10.1186/gb-2004-5-10-r80.
14. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
15. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, et al. (2008) Real-time PCR quantification of precursor and mature microRNA. Methods 44: 31-38 doi:10.1016/j.ymeth.2007.09.006.
16. Box GEP, Tiao GC (1973) Nature Of Bayesian Inference. Bayesian Inference In Statistical Analysis. Wiley Classics Library. 1-75.
17. The Case for Objective Bayesian Analysis, (2006) Bayesian Analysis. 1: 385-402 doi:10.1214/06-BA115.
18. Lunn D, Spiegelhalter D, Thomas A, Best N, (2009) The BUGS project: Evolution, critique and future directions. Stat Med 28: 3049-3067 doi:10.1002/sim.3680.
19. Held L, (2004) Simultaneous Posterior Probability Statements from Monte Carlo Output. Journal of Computational and Graphical Statistics 13: 20-35.
20. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA Targets. PLoS Biol 2: e363 doi:10.1371/journal.pbio.0020363.
21. Friedman RC, Farh KK-H, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105 doi:10.1101/gr.082701.108.
22. Wang X, El Naqa IM, (2008) Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24: 325-332 doi:10.1093/bioinformatics/btm595.
23. Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Research 37: D619-D622 doi:10.1093/nar/gkn863.
24. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29 doi:10.1038/75556.
25. Wang G, Kwan BC-H, Lai FM-M, Choi PC-L, Chow K-M, et al. (2010) Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 23: 78-84 doi:10.1038/ajh.2009.208.
26. Denby L, Ramdas V, McBride MW, Wang J, Robinson H, et al. (2011) miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 179: 661-672 doi:10.1016/j.ajpath.2011.04.021.
27. Bai X-Y, Ma Y, Ding R, Fu B, Shi S, et al. (2011) miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 22: 1252-1261 doi:10.1681/ASN.2010040367.
28. Wang G, Tam LS, Li EKM, Kwan BCH, Chow KM, et al. (2011) Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20: 493-500 doi:10.1177/0961203310389841.
29. Dai Y, Sui W, Lan H, Yan Q, Huang H, et al. (2009) Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29: 749-754 doi:10.1007/s00296-008-0758-6.
30. Wang G, Kwan BC-H, Lai FM-M, Chow K-M, Kam-Tao Li P, et al. (2010) Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers 28: 79-86 doi:10.3233/DMA-2010-0687.
31. Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, et al. (2011) Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21812927. Accessed 25 September 2011.
32. Phillips AO, Steadman R, Morrisey K, Martin J, Eynstone L, et al. (1997) Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 52: 973-984.
33. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, et al. (2009) MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 11: 1031-1038 doi:10.1038/ncb1917.
34. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, et al. (2010) miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9: 291-296 doi:10.1111/j.1474-9726.2010.00549.x.
35. Sun H, Li Q-W, Lv X-Y, Ai J-Z, Yang Q-T, et al. (2010) MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation. Mol Biol Rep 37: 2951-2958 doi:10.1007/s11033-009-9861-3.
36. Tran U, Zakin L, Schweickert A, Agrawal R, Döger R, et al. (2010) The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development 137: 1107-1116 doi:10.1242/dev.046045.
37. Hou J, Shan Q, Wang T, Gomes AS, Yan Q, et al. (2007) Transgenic RNAi Depletion of Claudin-16 and the Renal Handling of Magnesium. Journal of Biological Chemistry 282: 17114-17122 doi:10.1074/jbc.M700632200.
38. Mahimainathan L, Das F, Venkatesan B, Choudhury GG, (2006) Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 55: 2115-2125 doi:10.2337/db05-1326.
39. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, et al. (2010) MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10: 367 doi:10.1186/1471-2407-10-367.
40. Fatima S, Zhou S, Sorrentino BP, (2012) Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. Stem Cells 30: 210-221 doi:10.1002/stem.1002.
41. Liao R, Sun J, Zhang L, Lou G, Chen M, et al. (2008) MicroRNAs play a role in the development of human hematopoietic stem cells. J Cell Biochem 104: 805-817 doi:10.1002/jcb.21668.
42. Valera VA, Walter BA, Linehan WM, Merino MJ, (2011) Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer 2: 515-526.
43. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, et al. (2010) microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30: 1562-1568 doi:10.1161/ATVBAHA.110.206201.
44. Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF, (2011) MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia 54: 1930-1940 doi:10.1007/s00125-011-2125-5.
45. Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, et al. (2010) Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest 120: 4141-4154 doi:10.1172/JCI42980.
46. Chamorro-Jorganes A, Araldi E, Penalva LOF, Sandhu D, Fernández-Hernando C, et al. (2011) MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1. Arteriosclerosis, Thrombosis, and Vascular Biology. Available:http://www.ncbi.nlm.nih.gov/pubmed/21885851. Accessed 25 September 2011.
47. Kato M, Zhang J, Wang M, Lanting L, Yuan H, et al. (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437 doi:10.1073/pnas.0611192104.
48. Kato M, Arce L, Wang M, Putta S, Lanting L, et al. (2011) A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney Int 80: 358-368 doi:10.1038/ki.2011.43.
49. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, et al. (2010) Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy. Journal of the American Society of Nephrology 21: 438-447 doi:10.1681/ASN.2009050530.
50. Macconi D, Tomasoni S, Romagnani P, Trionfini P, Sangalli F, et al. (2012) MicroRNA-324-3p Promotes Renal Fibrosis and Is a Target of ACE Inhibition. JASN 23: 1496-1505 doi:10.1681/ASN.2011121144.
51. García-Sánchez O, López-Hernández FJ, López-Novoa JM, (2010) An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int 77: 950-955 doi:10.1038/ki.2010.88.
52. Ostendorf T, Eitner F, Floege J (2011) The PDGF family in renal fibrosis. Pediatr Nephrol. Available:http://www.ncbi.nlm.nih.gov/pubmed/21597969. Accessed 4 September 2011.
53. Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, et al. (2011) FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy. Clinical Journal of the American Society of Nephrology 6: 241-247 doi:10.2215/CJN.04250510.
54. Heese K, Beck K-F, Behrens MH, Plüss K, Fierlbeck W, et al. (2003) Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells. Biochem Pharmacol 65: 293-301.
55. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, et al. (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 98: 6162-6167 doi:10.1073/pnas.101130898.
56. Bonofiglio R, Antonucci MT, Papalia T, Romeo F, Capocasale G, et al. (2007) Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys. J Nephrol 20: 186-195.
57. Shan D, Wu HM, Yuan QY, Li J, Zhou RL, et al. (2012) Pentoxifylline for diabetic kidney disease. Cochrane Database Syst Rev 2: CD006800 doi:10.1002/14651858.CD006800.pub2.
58. Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, et al. (2011) Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22: 1144-1151 doi:10.1681/ASN.2010101049.
59. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, et al. (2011) Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365: 327-336 doi:10.1056/NEJMoa1105351.
60. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, et al. (2004) Preventing microalbuminuria in type 2 diabetes. N Engl J Med 351: 1941-1951 doi:10.1056/NEJMoa042167.
61. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, et al. (2011) Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 364: 907-917 doi:10.1056/NEJMoa1007994.
62. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, et al. (2011) MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Available:http://www.ncbi.nlm.nih.gov/pubmed/21794090. Accessed 25 September 2011.
63. Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JYZ, et al. (2011) Circulating microRNA expression is reduced in chronic kidney disease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association- European Renal Association. Available:http://www.ncbi.nlm.nih.gov/pubmed/21891774. Accessed 25 September 2011.
64. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741 doi:10.1373/clinchem.2010.147405.